Skip to main content
. 2016 Jul 13;53(2):583–620. doi: 10.3233/JAD-151146

Fig.33.

Fig.33

Relation between an AVN-101 dose upon PO administration and blood concentration of AVN-101 and its two metabolites, M1 and M2, in humans. A) Peak concentration, Cmax (mean ± SD). B) Exposure, AUC (mean ± SD).